PPT Slide

• An oral form of PTH (parathyroid hormone) or Forteo™, is being developed by Lilly and EMIS to treat osteoporosis

• Osteoporosis is estimated to cost the healthcare system $13.8 billion annually

Forteo™: A Case Study

Proving the Technology

Previous slide

Next slide

Back to first slide

View graphic version